Title:
神経変性疾患および脳の癌の処置
Document Type and Number:
Japanese Patent JP4638148
Kind Code:
B2
Abstract:
A composition comprising suberoylanilide hydroxamic acid (SAHA) represented by the following structure:
or a pharmaceutically acceptable salt or hydrate thereof, and a Pharmaceutical acceptable carrier or diluent, for use in the treatment of brain cancer in a mammal, wherein the composition is formulated for oral administration.
Inventors:
Ricorn, Victoria M.
Marks, Paul A.
Rifkind, Richard A.
Marks, Paul A.
Rifkind, Richard A.
Application Number:
JP2003535727A
Publication Date:
February 23, 2011
Filing Date:
October 16, 2002
Export Citation:
Assignee:
Sloan-Kettering Institute for Cancer Research
International Classes:
A61K31/166; C12N9/99; A61K31/00; A61K31/16; A61K31/167; A61K31/19; A61K31/4406; A61K31/47; A61K31/4706; A61K31/4709; A61P21/04; A61P25/00; A61P25/08; A61P25/14; A61P25/16; A61P25/28; A61P27/02; A61P35/00; A61P43/00; C07D213/75; C07D215/40
Domestic Patent References:
| JP11302173A | ||||
| JP11335375A | ||||
| JP2000256194A | ||||
| JP7502494A | ||||
| JP4500359A | ||||
| JP2001354694A | ||||
| JP2004504347A | ||||
| JP2004509105A |
Foreign References:
| WO2000021979A1 |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita